BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35361561)

  • 1. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
    Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
    J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.
    Alibhai SM; Aziz S; Manokumar T; Timilshina N; Breunis H
    J Geriatr Oncol; 2017 Jan; 8(1):31-36. PubMed ID: 27756545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
    Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
    J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
    Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
    J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
    Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
    J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric 8 and Vulnerable Elders Survey-13 predict length of hospital stay and postoperative complications in Japanese patients undergoing urological surgery.
    Tokura Y; Kawai T; Takei K; Ujiie T; Kanatani A; Yamada Y; Kaneko T; Kamai T; Nakagawa T
    J Geriatr Oncol; 2023 Jul; 14(6):101558. PubMed ID: 37327760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
    Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer.
    Ortland I; Mendel Ott M; Kowar M; Sippel C; Jaehde U; Jacobs AH; Ko YD
    J Geriatr Oncol; 2020 Jul; 11(6):997-1005. PubMed ID: 31928942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology.
    Zhang J; Liao X; Feng J; Yin T; Liang Y
    Oncol Lett; 2019 Nov; 18(5):4947-4955. PubMed ID: 31612006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.
    Rowbottom L; Loucks A; Jin R; Breunis H; Syed AT; Watt S; Timilshina N; Puts M; Yokom D; Berger A; Alibhai SMH
    J Geriatr Oncol; 2019 Mar; 10(2):229-234. PubMed ID: 30420323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):210-215. PubMed ID: 30503312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and effects of toxicity experienced by older adults with cancer receiving systemic therapy in a randomized clinical trial of geriatric assessment.
    Mariano C; Brennenstuhl S; Alibhai S; Tejero I; Strohschein F; Monette J; Szumacher E; Hsu T; Puts M
    J Geriatr Oncol; 2023 Sep; 14(7):101584. PubMed ID: 37429107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.
    Hentschel L; Rentsch A; Lenz F; Hornemann B; Schmitt J; Baumann M; Ehninger G; Schuler M
    Oncol Res Treat; 2016; 39(4):210-6. PubMed ID: 27160741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement analysis between three different short geriatric screening scales in patients undergoing chemotherapy for solid tumors.
    Joshi A; Tandon N; Patil VM; Noronha V; Gupta S; Bhattacharjee A; Prabhash K
    J Cancer Res Ther; 2017; 13(6):1023-1026. PubMed ID: 29237969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
    AlSendi M; Flynn CR; Khan MR; Selvadurai P; Crown J; McDermott RS; Walshe JM; Fennelly DW; Hanrahan EO; Doherty M; Higgins MJ
    Ir J Med Sci; 2024 Feb; 193(1):45-50. PubMed ID: 37450258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Cancer and Aging Research Group Predictive Model for Chemotherapy-Related Toxic Effects in a Multiethnic, Older Adult Asian Population.
    Pang A; Jiali L; Ng A; Cheng J; Wang M; Ng YS; Yao Y; Chun M; Ho F; Tey J
    JAMA Netw Open; 2022 Oct; 5(10):e2237196. PubMed ID: 36255721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.
    Agemi Y; Shimokawa T; Sasaki J; Miyazaki K; Misumi Y; Sato A; Aida S; Ishii M; Nakamura Y; Naoki K; Okamoto H
    PLoS One; 2019; 14(1):e0210499. PubMed ID: 30653558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.